ERASCA, INC. (ERAS)
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lakefront Biotherapeutics rapporteert halfjaarcijfers 2026 en geeft een update over de activiteiten
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
MySize Announces Reverse Stock Split
NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital
iHeartMedia, Inc. Reports Results for 2026 Second Quarter
Riot Platforms Reports Second Quarter 2026 Financial Results and Strategic Highlights